NeuroSense Therapeutics Ltd.
NRSN
$0.83
-$0.02-2.86%
NASDAQ
| 12/31/2025 | 06/30/2025 | 12/31/2024 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -95.09% | -44.87% | 27.95% | -43.64% | |
| Total Receivables | -79.88% | 125.27% | -1.20% | -27.29% | |
| Inventory | -38.75% | -- | -- | -- | |
| Prepaid Expenses | -8.05% | -- | 24.29% | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | 34.29% | 22.86% | -12.50% | 60.87% | |
| Total Current Assets | -82.33% | -3.89% | 50.96% | -42.59% | |
|
|
|||||
| Total Current Assets | -82.33% | -3.89% | 50.96% | -42.59% | |
| Net Property, Plant & Equipment | 52.00% | -47.50% | -39.27% | -14.47% | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | -4.35% | 4.55% | 4.55% | -38.24% | |
| Total Assets | -77.53% | -8.53% | 43.64% | -41.65% | |
|
|
|||||
| Total Accounts Payable | -31.12% | -26.30% | -20.49% | 343.20% | |
| Total Accrued Expenses | 113.31% | -- | -60.69% | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 34.25% | -- | 5.80% | -- | |
| Total Finance Division Other Current Liabilities | -- | -45.19% | -- | -- | |
| Total Other Current Liabilities | -- | -45.19% | -- | -- | |
| Total Current Liabilities | 26.31% | -37.20% | -42.41% | 246.36% | |
|
|
|||||
| Total Current Liabilities | 26.31% | -37.20% | -42.41% | 246.36% | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -51.45% | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | 572.25% | |
| Total Liabilities | 29.92% | -37.84% | -59.71% | 303.32% | |
|
|
|||||
| Common Stock & APIC | 17.79% | 33.15% | 61.08% | 13.49% | |
| Retained Earnings | -30.35% | -27.75% | -40.35% | -65.09% | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | -160.39% | 69.52% | 246.84% | -102.50% | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | -160.39% | 69.52% | 246.84% | -102.50% | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | -160.39% | 69.52% | 246.84% | -102.50% | |
|
|
|||||